Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1994 May;62(5):1843–1847. doi: 10.1128/iai.62.5.1843-1847.1994

Site-directed mutagenesis of the alpha-toxin gene of Staphylococcus aureus: role of histidines in toxin activity in vitro and in a murine model.

B E Menzies 1, D S Kernodle 1
PMCID: PMC186423  PMID: 8168947

Abstract

Staphylococcus aureus alpha-toxin is a membrane-damaging exoprotein that oligomerizes to form transmembrane pores. Chemical modification of histidines with diethylpyrocarbonate has been shown to reduce the hemolytic activity of alpha-toxin, suggesting that one or more of the histidine residues is important for toxin function. To individually assess the functional importance of each of the four histidine residues (residues 35, 48, 144, and 259), we used oligonucleotide-directed mutagenesis of the cloned alpha-toxin gene to replace each histidine with leucine. The mutant toxins were expressed in S. aureus and evaluated for hemolytic activity in vitro and for lethality in an intraperitoneal murine model. Substitution of histidine 35 with leucine produced a mutant toxin (H35L) without hemolytic or lethal activity. Mutant toxins H48L, H144L, and H259L exhibited 7, 16, and 46%, respectively, of the hemolytic activity of wild-type toxin. Immunoblotting of purified H35L toxin incubated with liposomal membranes demonstrated intact membrane binding and hexamer formation that was clearly detectable but reduced compared with that of the wild-type toxin. This suggests that hexamer formation alone is not sufficient for the expression of alpha-toxin activity. The nature of the defect underlying the lack of activity of the H35L mutant toxin remains to be elucidated but may involve failure of the hexamer to span the lipid bilayer to form a transmembrane pore or a change in the internal surface and permeability characteristics of the pore.

Full text

PDF
1843

Images in this article

1845Image
on p.1845
1845Image
on p.1845

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bernheimer A. W. Assay of hemolytic toxins. Methods Enzymol. 1988;165:213–217. doi: 10.1016/s0076-6879(88)65033-6. [DOI] [PubMed] [Google Scholar]
  2. Bernheimer A. W. Staphylococcal alpha toxin. Ann N Y Acad Sci. 1965 Jul 23;128(1):112–123. doi: 10.1111/j.1749-6632.1965.tb11633.x. [DOI] [PubMed] [Google Scholar]
  3. Bhakdi S., Muhly M., Korom S., Hugo F. Release of interleukin-1 beta associated with potent cytocidal action of staphylococcal alpha-toxin on human monocytes. Infect Immun. 1989 Nov;57(11):3512–3519. doi: 10.1128/iai.57.11.3512-3519.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bhakdi S., Muhly M., Mannhardt U., Hugo F., Klapettek K., Mueller-Eckhardt C., Roka L. Staphylococcal alpha toxin promotes blood coagulation via attack on human platelets. J Exp Med. 1988 Aug 1;168(2):527–542. doi: 10.1084/jem.168.2.527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Blomqvist L., Thelestam M. Oligomerization of 3H-labelled staphylococcal alpha-toxin and fragments on adrenocortical Y1 tumour cells. Microb Pathog. 1988 Mar;4(3):223–229. doi: 10.1016/0882-4010(88)90072-1. [DOI] [PubMed] [Google Scholar]
  6. Cassidy P., Harshman S. Purification of staphylococcal alpha-toxin by adsorption chromatography on glass. Infect Immun. 1976 Mar;13(3):982–986. doi: 10.1128/iai.13.3.982-986.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cescatti L., Pederzolli C., Menestrina G. Modification of lysine residues of Staphylococcus aureus alpha-toxin: effects on its channel-forming properties. J Membr Biol. 1991 Jan;119(1):53–64. doi: 10.1007/BF01868540. [DOI] [PubMed] [Google Scholar]
  8. Fairweather N., Kennedy S., Foster T. J., Kehoe M., Dougan G. Expression of a cloned Staphylococcus aureus alpha-hemolysin determinant in Bacillus subtilis and Staphylococcus aureus. Infect Immun. 1983 Sep;41(3):1112–1117. doi: 10.1128/iai.41.3.1112-1117.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Füssle R., Bhakdi S., Sziegoleit A., Tranum-Jensen J., Kranz T., Wellensiek H. J. On the mechanism of membrane damage by Staphylococcus aureus alpha-toxin. J Cell Biol. 1981 Oct;91(1):83–94. doi: 10.1083/jcb.91.1.83. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gray G. S., Kehoe M. Primary sequence of the alpha-toxin gene from Staphylococcus aureus wood 46. Infect Immun. 1984 Nov;46(2):615–618. doi: 10.1128/iai.46.2.615-618.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Harshman S., Alouf J. E., Siffert O., Baleux F. Reaction of staphylococcal alpha-toxin with peptide-induced antibodies. Infect Immun. 1989 Dec;57(12):3856–3862. doi: 10.1128/iai.57.12.3856-3862.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Harshman S., Boquet P., Duflot E., Alouf J. E., Montecucco C., Papini E. Staphylococcal alpha-toxin: a study of membrane penetration and pore formation. J Biol Chem. 1989 Sep 5;264(25):14978–14984. [PubMed] [Google Scholar]
  13. Harshman S., Sugg N., Cassidy P. Preparation and purification of staphylococcal alpha toxin. Methods Enzymol. 1988;165:3–7. doi: 10.1016/s0076-6879(88)65004-x. [DOI] [PubMed] [Google Scholar]
  14. Harshman S., Sugg N., Gametchu B., Harrison R. W. Staphylococcal alpha-toxin: a structure-function study using a monoclonal antibody. Toxicon. 1986;24(4):403–411. doi: 10.1016/0041-0101(86)90200-x. [DOI] [PubMed] [Google Scholar]
  15. Hebert T. E., Fackrell H. B. Inhibition of staphylococcal alpha-toxin by covalent modification of an arginine residue. Biochim Biophys Acta. 1987 Dec 18;916(3):419–427. doi: 10.1016/0167-4838(87)90188-9. [DOI] [PubMed] [Google Scholar]
  16. Kehoe M., Duncan J., Foster T., Fairweather N., Dougan G. Cloning, expression, and mapping of the Staphylococcus aureus alpha-hemolysin determinant in Escherichia coli K-12. Infect Immun. 1983 Sep;41(3):1105–1111. doi: 10.1128/iai.41.3.1105-1111.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kunkel T. A. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc Natl Acad Sci U S A. 1985 Jan;82(2):488–492. doi: 10.1073/pnas.82.2.488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Menestrina G., Belmonte G., Parisi V., Morante S. Structural features of the pore formed by Staphylococcus aureus alpha-toxin inferred from chemical modification and primary structure analysis. FEMS Microbiol Immunol. 1992 Sep;5(1-3):19–28. doi: 10.1111/j.1574-6968.1992.tb05882.x. [DOI] [PubMed] [Google Scholar]
  19. O'Reilly M., de Azavedo J. C., Kennedy S., Foster T. J. Inactivation of the alpha-haemolysin gene of Staphylococcus aureus 8325-4 by site-directed mutagenesis and studies on the expression of its haemolysins. Microb Pathog. 1986 Apr;1(2):125–138. doi: 10.1016/0882-4010(86)90015-x. [DOI] [PubMed] [Google Scholar]
  20. Palmer M., Weller U., Messner M., Bhakdi S. Altered pore-forming properties of proteolytically nicked staphylococcal alpha-toxin. J Biol Chem. 1993 Jun 5;268(16):11963–11967. [PubMed] [Google Scholar]
  21. Pederzolli C., Cescatti L., Menestrina G. Chemical modification of Staphylococcus aureus alpha-toxin by diethylpyrocarbonate: role of histidines in its membrane-damaging properties. J Membr Biol. 1991 Jan;119(1):41–52. doi: 10.1007/BF01868539. [DOI] [PubMed] [Google Scholar]
  22. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Thelestam M., Blomqvist L. Staphylococcal alpha toxin--recent advances. Toxicon. 1988;26(1):55–65. doi: 10.1016/0041-0101(88)90137-7. [DOI] [PubMed] [Google Scholar]
  24. Tobkes N., Wallace B. A., Bayley H. Secondary structure and assembly mechanism of an oligomeric channel protein. Biochemistry. 1985 Apr 9;24(8):1915–1920. doi: 10.1021/bi00329a017. [DOI] [PubMed] [Google Scholar]
  25. Vann J. M., Proctor R. A. Cytotoxic effects of ingested Staphylococcus aureus on bovine endothelial cells: role of S. aureus alpha-hemolysin. Microb Pathog. 1988 Jun;4(6):443–453. doi: 10.1016/0882-4010(88)90029-0. [DOI] [PubMed] [Google Scholar]
  26. Walker B., Krishnasastry M., Zorn L., Bayley H. Assembly of the oligomeric membrane pore formed by Staphylococcal alpha-hemolysin examined by truncation mutagenesis. J Biol Chem. 1992 Oct 25;267(30):21782–21786. [PubMed] [Google Scholar]
  27. Walker B., Krishnasastry M., Zorn L., Kasianowicz J., Bayley H. Functional expression of the alpha-hemolysin of Staphylococcus aureus in intact Escherichia coli and in cell lysates. Deletion of five C-terminal amino acids selectively impairs hemolytic activity. J Biol Chem. 1992 May 25;267(15):10902–10909. [PubMed] [Google Scholar]
  28. Watanabe M., Tomita T., Yasuda T. Membrane-damaging action of staphylococcal alpha-toxin on phospholipid-cholesterol liposomes. Biochim Biophys Acta. 1987 Apr 23;898(3):257–265. doi: 10.1016/0005-2736(87)90065-4. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES